The polyols, sorbitol and wyo-inositol, seem to be involved in the development of diabetic complications of different organs. High concentrations of both polyols were found in kidney medulla in addition to trimethylamines. To investigate the influence of diabetes mellitus on the regulation of both polyols and glycerophosphorylcholine in kidney, these osmolytes were quantitated enzymatically along the corticopapillary axis in untreated, streptozotocin-diabetic and insulin-treated streptozotocin-diabetic rats.
Introduction
. . - is present in glomeruh (3) and tubule cells of the renal The polyols, sorbitol and myo-inositol, are assumed inner medulla (4) . to be involved in the pathomechanisms of diabetic Beyer-Mears et al. found a sorbitol accumulation in complications. Thus sorbitol accumulation in various glomeruli of diabetic rats, which was reversed by cells was shown to correlate with diabetic ophthal-treatment with an aldose reductase inhibitor (5) . Inmopathy and neuropathy (1) . On the other hand a hibition of sorbitol formation by sorbinil prevented depletion of cellular mj;o-inositol in nerve cells has rena l hyperperfusion and hyperfiltration in diabetic been attributed to hyperglycaemia (2) . rats (6)> Little is known about changes in renal cortical rp, ι r+t. ι ι · A· u +· u Λ · ι raj;0-inositol concentrations under these conditions. The role of the polyols in diabetic nephropathy is less clear. As in other tissues, sorbitol is formed from In normal rats, polyol concentrations in the renal glucose by the action of aldose reductase. This enzyme medulla are much higher than in cortical structures (7, 8) . Sorbitol forms a steep gradient from the inner medulla to the papillary tip, whereas myo-inositol concentrations were shown to increase from the cortex to the outer medulla, slightly decreasing towards the papilla. In addition, glycerophosphorylcholine and betaine were accumulated in the renal inner and outer medulla (7) (8) (9) .
It is now well established that these substances act as organic osmolytes involved in intracellular osmo-adaptation of renal medullary cells (7 -9) . They were shown to be located intracellularly (8) and to fill the "osmotic gap" existing between the intracellular and interstitial space (10) . Under experimental conditions, the intracellular content of organic osmolytes changed in parallel with interstitial tonicity, depending on the diuretic state of the animal. A rapid decrease occurred during water and furosemide diuresis (8, 9, 11) , whereas antidiuresis increased inner medullary osmolytes.
Since sorbitol is formed from glucose by the action of aldose reductase, an increase is to be expected under hyperglycaemic conditions, as observed in other organs (1) . On the other hand, diuresis due to glucosuria might lead to a decrease in medullary sodium and therefore organic osmolyte content. Chauncey et al. (12) and Grunewald & Kinne (13) described an increase of inner medullary sorbitol paralleled by an increase in aldose reductase in diabetic rats, but these authors did not measure other osmolytes, and they did not determine the exact intrarenal localization of the observed changes.
The aim of the present study was to extend these studies by the simultaneous determination of glycerophosphorylcholine and myo-inositol in addition to sorbitol in five different kidney sections under diabetic conditions. Furthermore, the effect of insulin treatment on renal organic osmolytes was investigated.
Materials and Methods

Animals and experimental groups
Experiments were performed on 21 male Sprague-Dawley rats weighing 235 -290 g, kept on a standard laboratory diet with free access to tap water. The animals were divided into three groups:
Group 1
Four untreated control rats.
Group 2
Eight rats injected with 100 mg/kg body weight streptozotocin (SIGMA, Deisenhofen, Germany) into the tail vein under light ether anaesthesia on day 0. From day 1 to day 6 each rat received two daily subcutaneous injections of 5 U pig insulin (Alt-Insulin vom Schwein, Hoechst, Frankfurt, Germany) at 11 a.m. and 10 p.m. Insulin was withdrawn on day 7 and 8.
Group 3
Nine rats treated as in group 2, but insulin treatment continued on day 7 and 8.
All animals were weighed and glucose and ketone bodies monitored daily in urine with teststrips (Ketodiabur 5000, Boehringer Mannheim, Mannheim, Germany).
On the last day of the experiment (day 8), animals were anaesthesized with a single intraperitoneal nembutal injection (CEVA, Paris, France). After laparatomy, urine was obtained by punction of the bladder and centrifuged for 2 min at 10 000 g. The sediment-free supernatant was stored at -20 °C. Blood was collected from the aorta into an heparinized tube, centrifuged for 15 min at 2000 £, and the plasma stored at -20 °C. Both kidneys were excised, washed free from blood with icecold isotonic saline, and immediately processed as described below.
Preparation of homogenates
Kidneys were placed on a cooled (+4 °C) Petri dish and sliced into papillary tip (IM3), papillary base (IM2), remainder of inner medulla (IM1), outer medulla and cortex, as described previously (8) , and stored at -20°C. Each slice (3-30 mg fresh weight) was homogenized in 1 ml ice-cold 0.3 mol/1 HC1O 4 . Between 100 and 300 μΐ of the homogenate were used for protein determination by a modified biuret procedure (8) . The remaining 700 -900 μΐ were centrifuged for 5 min at 10000g. To hydrolyse glycerophosphorylcholine, an aliquot of 140 μΐ of this supernatant was incubated for l h at 95 °C (14) . Hydrolysed and unhydrolysed supernatants (kept on ice) were neutralized with solid KHCO 3 .
Analytical procedures
Glycerophosphorylcholine
Glycerophosphorylcholine was determined enzymatically using choline kinase 1 ) as described by Wirthensohn et al. (14) , with a detection limit of 4 nmol and a coefficient of variation of 10% at 0.5-1 mmol/1.
Sorbitol
was measured enzymatically by sorbitol dehydrogenase 1 ) as described for xylitol (15) using a kit from Boehringer Mannheim, Mannheim, Germany (cat. No. 670057).
myo-Inositol
wyo-Inositol was determined by an enzymatic method using my -inositol dehydrogenase. Formed NADH is linked to a colour-forming reaction as described by Dolhofer & Wieland (16) .
Glucose
Glucose in tissue homogenates was measured enzymatically with a hexokinase 1 ) method. Blood and urine glucose was determined kinetically on an automated analyser (ACP 5040, Eppendorf, Hamburg, Germany) using glucose dehydrogenase 1 ) (Merck, Darmstadt, Germany) (17) .
Glycated proteins
Glycated plasma proteins were measured as furosine in plasma protein hydrolysates using the HPLC procedure described by Schleicher & Wieland (18) .
Urine osmolytes
Urinary sodium and potassium were determined by flame photometry (Eppendorf AFM 5051, Hamburg, Germany) and osmolality with a freeze point osmometer (Vogel, Gießen, Germany). Creatinine was measured kinetically by the method of Jaffe adapted to the Kone Specific analyser (Kone, Turku, Finland) as described by Hofmann et al. (19) .
Choline kinase: ATPicholine phosphotransferase, EC 2.7.1.32 Glucose dehydrogenase: ß-£>-glucose: NAD(P) 1-oxidoreductase, EC 1. (20) .
Results
Characterization of animals
Body weights
The body weight of control animals continuously increased from day 0 (255 ± 6 g) to day 8 (310 ± 11 g). Two days after streptozotocin treatment body weight decreased only slightly and remained nearly constant despite insulin treatment (tab. 1).
Withdrawal of insulin during day 7 and 8 in group 2 resulted in a slight, but significant decrease vs day 6 (not shown). 
Urine and blood glucose and glycated proteins
As expected, diabetic rats showed a marked hyperglycaemia (25.0 + 1.9 vs 9.1 mmol/1 in control rats) and glucosuria (538.1 ± 8.7 vs 1.0 ± 0.4 mmol/1 in control rats), which was almost normalized by a 97% decrease after insulin treatment (tab. 1). In contrast, the concentrations of glycated plasma proteins in diabetic (1.8 ±0.1 mmol/kg protein) and insulintreated diabetic rats (1.4 + 0.2 mmol/kg protein) were elevated above that observed in control animals (0.8 ± 0.1 mmol/kg protein). This indicates that the insulin-treated diabetic rats had been in a diabetic metabolic state.
Urinary osmolytes
The diabetes-induced glucosuria was accompanied by an osmotic diuresis, which was expressed in markedly decreased urinary potassium, sodium and creatinine concentrations (tab. 1). In contrast, diabetic animals had only a slightly lowered urine osmolality. Insulin treatment restored all measured urinary quantities to the values found in untreated control rats (tab. 1).
Tissue contents of organic osmolytes and glucose
Control
In control animals organic osmolytes showed the same distribution patterns along the corticopapillary axis as described previously (8) . Sorbitol exhibited a steep gradient from the inner medulla to the papillary tip, glycerophosphorylcholine from the outer medulla to the papilla, whereas wy0-inositol increased from the cortex to the outer medulla then decreased slightly towards papillary tip ( fig. la-c) . Glucose decreased sharply from the cortex (42.7 ±1.1 mmol/kg protein) to outer medulla (5.2 ±1.5 mmol/kg protein), followed by a continuous increase towards the papillary tip (21.7 ± 2.9 mmol/kg protein) (tab. 2).
Diabetes mellitus
In diabetic rats dramatic changes in renal glucose and sorbitol content were observed, whereas glycerophosphorylcholine and wyo-inositol were less affected.
Glucose drastically increased in all kidney sections (7) • , · 2) . The sharp decrease observed in control animals from the cortex to the outer medulla was no longer apparent. However, the threefold increase from the outer to the inner medulla persisted, but at a 20-fold higher level.
Sorbitol increased 2.5, 5.1 and 3.3-fold in the papillary tip, papillary base and the rest of inner medulla, respectively. In contrast to glucose, no change in the distribution pattern of sorbitol was observed ( fig. la) .
Glycerophosphorylcholine, on the other hand, was slightly decreased in all inner medullary sections, compared with control animals, whereas the outer medulla and cortex showed a significant increase ( fig. Ib) .
In contrast to these findings, wyo-inositol was not affected by the diabetic state of the animal. Only the outer medullary region exhibited an increase (20%) in myo-inositol (p < 0.05) (fig. Ic).
Insulin treatment
As expected from the observed decrease of urinary and blood glucose, insulin treatment restored the tissue glucose content to control values in all kidney sections, with reappearance of the original profile along the corticopapillary axis. In parallel with urinary glucose, papillary glucose was slightly, but significantly elevated when compared with controls (tab. 2).
Insulin significantly reduced tissue sorbitol concentrations in all layers of the kidney ( fig. la) . In contrast to glucose, however, sorbitol was only partially restored in papillary tissue, remaining 1.6 and 2-fold higher than in the papillary tip and papillary base of control animals, respectively.
Glycerophosphorylcholine showed an opposite behaviour to that of sorbitol after insulin treatment of diabetic rats. In the papillary tip glycerophosphorylcholine was significantly higher than in untreated diabetic rats. No change was found in the papillary base and cortex. In the remaining inner medulla (IM1) and outer medulla insulin treatment led to lower glycerophosphorylcholine contents compared with diabetics rats (fig. Ib) . Except for the decrease in the IM1 region, the glycerophosphorylcholine concentrations in insulin-treated diabetic rats were not significantly different from those of control rats.
rayolnositol was not affected by insulin treatment. Except for a slight, but significant increase of myoinositol in the cortex, the concentrations were comparable to those of control and diabetic animals ( fig. Ic) .
Discussion
The present study describes for the first time the behaviour of three organic osmolytes in diabetic and insulin-treated diabetic animals. Sorbitol, wyo-inositol and glycerophosphorylcholine were quantitated in five separate kidney sections. Organic osmolytes located intracellularly had been previously measured under diuresis caused by furosemide (8, 9, 11) , water load (9) and lack of endogenous vasopressin production (21) . Under these conditions a loss of all organic osmolytes was observed (8, 9, 11, 21) , indicating an osmoregulatory role of these substances in the renal medulla.
The results show that each of these substances reacts in a typical and site-specific way to the diuretic state that occurs in diabetes mellitus.
Sorbitol
The observed increase in renal sorbitol in hyperglycaemic states agrees with the findings of Chauncey et al. (12) and Grunewald & Kinne (13) . The changes shown in the present study are, however, larger than those documented by these authors. This is probably due to the fact that in these earlier studies sorbitol was measured in the total inner medulla (IM1 -IM3).
Since the greatest changes in sorbitol concentrations are found in the renal papilla, analysis of total inner medulla can be expected to "dilute" the changes occurring in this subfraction.
These observations point to the physiological function of the so called "polyol pathway", which has often been assumed to be a merely "side effect" of the diabetic state. Our results imply that sorbitol formation in medullary cells may be a useful mechanism for compensating changes in extracellular osmolality caused by glucose. Furthermore, the distribution pattern of aldose reductase in single nephron segments (4) clearly correlates with that of sorbitol as shown in recent microdissection studies (22) . Its enzymatic activity increases with diabetes mellitus (13) .
The high extracellular glucose in the inner medullary regions seems to be an additional reason for the increase in tubular sorbitol. A threefold increase in tubular sorbitol content was observed in vitro in inner medullary tubule suspensions (8) , after increasing extracellular glucose from 5 to 20 mmol/1.
The observation that continuous insulin treatment over eight days was not sufficient to diminish tubular sorbitol to control values raises the questions about the possible mechanisms of sorbitol depletion by renal inner medullary cells. Enzymatic conversion of sorbitol to fructose by sorbitol dehydrogenase is generally accepted as the metabolic pathway of sorbitol degradation. Interestingly, this enzyme is nearly exclusively found in renal cortex (12) , especially in proximal tubules (4), rather than in inner and outer medulla (4). However, when inner medullary tubule suspensions were incubated with media of varying salinity, the sum of tubular and medium sorbitol content remained constant (8) . This observation supports the conclusion that sorbitol metabolism does not contribute to any major extent to inner medullary sorbitol depletion. On the other hand, a rapid decrease of intracellular sorbitol (and the other osmolytes) was observed under isotonic conditions in vitro (8) . A sorbitol-specific permease has been postulated to regulate intracellular sorbitol concentrations (23) . This transporter seems to be controlled by changes in cell volume caused by the variation of extracellular tonicity.
The intermediate tissue sorbitol concentrations in insulin-treated diabetic rats can be explained by assuming two simultaneously acting mechanisms. On the one hand, the decrease in glucose availability after insulin treatment leads to a decrease in sorbitol synthesis that would result in tissue sorbitol concentrations similar to those of control animals. On the other hand, the increasing sodium concentrations, with unchanged urine osmolality, would need a constant level of counteracting intracellular osmolytes. The latter mechanism would keep the osmolality-dependent sorbitol permease unchanged. The observation that the decrease of sorbitol in the papillary tip was counteracted by an increase in glycerophosphorylcholine leads to the interesting question of whether another organic osmolyte compensates the decrease of sorbitol under these circumstances. Such mechanisms are implied by the observation in cultured papillary cells, that decreasing intracellular sorbitol concentrations, due to inhibition of aldose reductase by tolrestat, were compensated by corresponding increase of betaine (24) .
Trimethylamines
The distribution pattern of glycerophosphorylcholine, recognized as organic osmolyte decades ago (25) , differs from that of sorbitol; nearly equal concentrations are found in the papillary tip and base, decreasing to 50% and 5% in the remaining inner medulla and outer medulla, respectively (8, 9, 21). Under diabetic conditions, glycerophosphorylcholine concentrations decreased in papillary and increased in outer medullary sections, leading to a change in its distribution pattern. The decrease in the papillary tip in diabetes agrees with the behaviour of this osmolyte in other diuretic states where glycerophosphorylcholine concentrations have been correlated with extracellular urea and sodium concentrations (26) . Under in vivo conditions glycerophosphorylcholine concentrations follow those of urinary sodium and urea in water dehydration (9, 26) , vasopressin treatment of diabetes insipidus rats (21) and sodium loading (27) . This osmolyte was assumed to represent the concentrating ability of the entire kidney and to be independent of glucose. This latter assumption was supported by experiments with isolated inner medullary tubules, showing that glucose had no effect on glycerophosphorylcholine concentrations (8) . The increasing effect of insulin treatment on papillary glycerophosphorylcholine is also in accordance with this idea, because it increased in parallel with urinary urea and sodium.
The elevated glycerophosphorylcholine concentrations in the outer medulla in the diabetic state point to a different function of the cells in this kidney region. Since this section consists of several tubular segments with individual functions, no functional correlation can be discussed at present.
Cellular rayo-inositol depletion has been discussed as a pathogenetic mechanism in diabetic neuropathy (2) and nephropathy (5) . The lack of significant changes in the present study does not accord with this concept, but confirms recent findings of Loy et al. (28) . In the cortex, myö-inositol was increased rather than decreased, whereas no change was found in all medullary sections. In contrast to sorbitol and glycerophosphorylcholine, rayo-inositol seems to be taken up from the extracellular space into the tubular cells. A sodium-dependent uptake mechanism has been described in cortical and outer medullary tubules (29) . In conclusion the increase in cortical rayo-inositol may be caused by the increase of plasma myö-inositol observed under diabetic conditions by Dolhofer & Wieland (\6) .
The relative constancy of wyo-inositol concentrations during osmoregulatory changes was also observed during vasopressin treatment of diabetes insipidus rats (21) , water deprivation (8, 11, 30) , and after inhibition of aldose reductase by sorbinil in normal and antidiuretic rats (30) . The different distribution pattern of m^o-inositol, with the highest concentrations in the outer medullary region, points to a different tubular localization, which has recently been confirmed by microdissection (22) . The thick ascending limbs have been shown to contain high concentrations of myoinositol but not sorbitol, whereas both polyols are present in the inner medullary collecting ducts.
The lack of changes in medullary myo-'mositol in diabetes mellitus and insulin treatment indicates that this osmolyte does not play a major role in the regulation of the renal concentrating mechanism, and is not responsible for renal diabetic complications under these conditions.
